#liverdisease

Merck to Acquire Terns Pharmaceuticals

Merck is reportedly nearing a deal to acquire Terns Pharmaceuticals, a company focused on developing treatments for liver diseases. The acquisition would expand Merck's portfolio in this therapeutic area.